| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 46.314.000 $ | +8.584.358 $ | +22,8 % | 1 | 57.616.042 $ | -28.047.321 $ | -32,7 % | 2 | 106.742.922 $ | +16.706.709 $ | +23,2 % | 3 | ||||
| Aura Biosciences, Inc. | AURA | → 0 | Neutral | 46.314.000 $ | +8.584.358 $ | +22,8 % | 1 | 37.729.642 $ | -5.053.695 $ | -11,8 % | 1 | 42.783.337 $ | -553.829 $ | -1,3 % | 1 |
| Maze Therapeutics, Inc. | MAZE | → 0 | Schwach | 19.886.400 $ | -22.993.626 $ | -53,6 % | 1 | 42.880.026 $ | +12.374.548 $ | +40,6 % | 1 | ||||
| Zentalis Pharmaceuticals, Inc. | ZNTL | → 0 | Schwach | 21.079.559 $ | +4.885.990 $ | +30,2 % | 1 | ||||||||
| 46.314.000 $ | +8.584.358 $ | +22,8 % | 1 | 57.616.042 $ | -28.047.321 $ | -32,7 % | 2 | 106.742.922 $ | +16.706.709 $ | +23,2 % | 3 | ||||